A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])
Clinical trial NCT04835714 · TERMINATED
Trial details
- NCT number
- NCT04835714
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2022-01-18
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.